Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
about
Optimum second-line regimens for Helicobacter pylori eradicationHelicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerH. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerPathogenesis of Helicobacter pylori infectionSecond and third line treatment options for Helicobacter pylori eradicationBlue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?Peptic ulcer disease today'Rescue' therapies for the management of Helicobacter pylori infection.Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.Second-line rescue therapy of helicobacter pylori infection.The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in KoreaRifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.New strategies for the prevention and treatment of Helicobacter pylori infection.Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures.Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pyloriDevelopment potential of rifalazil.Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.Trends in peptic ulcer pharmacotherapy.Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradicationRecombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pyloriDual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.Molecular biology methods for the characterization of Helicobacter pylori infections and their diagnosis.Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.Helicobacter pylori "rescue" therapy after failure of two eradication treatments.Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.Eradication of Helicobacter pylori: are rifaximin-based regimens effective?Effective regimens for the treatment of Helicobacter pylori infection.Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic.Evolution of Helicobacter pylori therapy from a meta-analytical perspective.Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea.A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experienceTailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis"Rescue" regimens after Helicobacter pylori treatment failure.Review article: the global emergence of Helicobacter pylori antibiotic resistance.High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.The sequential therapy regimen for Helicobacter pylori eradication.Second-line and third-line trial for helicobacter pylori infection in patients with duodenal ulcers: A prospective, crossover, controlled study.
P2860
Q24193213-5B52DB9E-471F-4742-9C72-2BD925F431B1Q24247126-076A7068-78A8-47B3-A4AA-78D2FBA311AAQ24248627-23E85520-C3CE-4595-8F9D-C8C9B4A1288EQ24679810-7338FEE3-0645-47E3-9FFD-8EA246E47558Q26829666-A99EF56F-9318-491D-B514-6A302045EF8CQ26862392-51233A7C-178F-45F2-876B-F10BF4440381Q28194844-848861BC-1E6F-4E42-B789-0A208349D1B3Q33371187-7F7DB13D-EDB6-43B3-9BB0-FA93A668FD48Q33916743-A4A8993E-F8E1-4ABE-BACC-560B6B1D1052Q34409114-30454897-601E-46C3-AC26-5AA4A6ADF0BBQ34432129-4D1E83B4-DEED-4CAC-A07F-0ED4FAD9ADC6Q34557101-7EE7F22B-A136-41A9-BABE-6F21E105B17DQ34768573-ADB120B1-210C-4523-8EB8-9B6511EF2246Q34774061-A3F7A1E7-8617-45E0-B985-7B6CDB78CEFFQ34823645-988C887B-F172-4AF5-8E7B-B06E198082CCQ35056073-22F3510D-2D34-4D92-9A3E-0298E0DE9C3EQ35594239-9070B487-BBB0-408F-B7D9-6BA94F529376Q35641362-F88566CD-2424-4FB9-AF60-096545474339Q35771863-1C7C2A67-4A7E-4ECA-B5FB-E96B06D2CC98Q35841617-1D4764BE-1C46-493B-A7C0-8D69F39ABCCCQ35843088-FC6F563B-7703-4E00-8B05-6BC8674A1FD6Q35849923-E01BC676-1E05-4A0F-8D7D-C8201E84AED1Q35997133-4F567B94-F40A-40BB-8589-C50B04B35951Q36028541-4C62B863-2589-4C68-BB5D-D7AD008D9190Q36132712-20543A02-AA07-4D0A-AA40-8D7140AD06ECQ36266517-B71658E6-ACED-44C9-A411-A4C071705A8BQ36360546-2339A1D0-9F38-4720-B34E-097383D91358Q36404971-DCCE38E5-115F-48EF-B717-991A2E8B335BQ36568724-AC8EC2FF-3E16-4B64-BCCB-8C72271FEF56Q36723844-25C90CE7-EDB7-40A7-87D0-ADF60AAC298EQ36996627-37BFC874-C91B-4A0E-BD80-75188CBB9F92Q37046537-1D96EF97-43B6-481D-8AD5-86CAD0BD1C5CQ37205675-ECDFCDFB-2860-45C0-AB9B-ED0A728A8E51Q37206124-96350D3D-5FBA-46F9-B3F0-65267D8FD215Q37273653-E6B0FC89-BAA6-4F5A-84FA-15D643E0B3C5Q37340339-F28F5452-A6FD-4F00-B5A1-0E1157C2919CQ37364909-F41EB6D6-CDCF-4279-B9FD-73161B015462Q37394555-1F178C7A-882F-4A50-B8B4-2C8BDDC6BCE7Q37703245-C1D55CA8-3DBC-4458-B3AF-217C88FF9809Q37719102-00E5E6A5-1AF6-4AB3-8C59-B52F5F758BA1
P2860
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Review article: Helicobacter p ...... r-based triple therapies fail.
@ast
Review article: Helicobacter p ...... r-based triple therapies fail.
@en
Review article: Helicobacter p ...... r-based triple therapies fail.
@nl
type
label
Review article: Helicobacter p ...... r-based triple therapies fail.
@ast
Review article: Helicobacter p ...... r-based triple therapies fail.
@en
Review article: Helicobacter p ...... r-based triple therapies fail.
@nl
prefLabel
Review article: Helicobacter p ...... r-based triple therapies fail.
@ast
Review article: Helicobacter p ...... r-based triple therapies fail.
@en
Review article: Helicobacter p ...... r-based triple therapies fail.
@nl
P2860
P1476
Review article: Helicobacter p ...... or-based triple therapies fail
@en
P2093
J M Pajares
P2860
P304
P356
10.1046/J.1365-2036.2002.01276.X
P407
P577
2002-06-01T00:00:00Z